Oculentis eye implant claims settled against major UK eye clinic
A number of patients' legal claims have been successfully settled against leading UK eye clinic Optegra using contract law which protects consumers.
Posted on 21 August 2019
We sometimes take our eyesight for granted, but problems with vision can have a significant impact on a person’s quality of life.”
Thomas Jervis, product liability solicitor at Leigh Day
The patients paid privately to undergo surgery to have intraocular lenses implanted into their eyes in order to assist with or to improve their vision, including as an alternative to the use of glasses.
Optegra, who describes itself as the UK’s most trusted eye hospital, provided the patients with specific types of Oculentis lenses which eventually became the subject of urgent Field Safety Notices issued by Oculentis on 4 December 2014 and 12 September 2017. The notices announced a voluntary recall of affected products on the basis of reports of lenses becoming cloudy and opaque after operation.
Leading product liability specialist Thomas Jervis from law firm Leigh Day brought the patients’ legal claims against their Optegra clinics using contract law which is in place to protect consumers, alleging that the lenses were not of a satisfactory quality pursuant to the Sale of Goods and Services Act 1982.
The patients also alleged that that implantation of the lenses in question led to further vision problems, the requirement for revision surgery and financial losses. The settlements were reached without an admission of liability.
Thomas Jervis said:
“My clients went to Optegra to try to improve their vision but they believe that they were instead left with further vision problems.
“The compensation secured will help to cover the costs of surgery and the financial losses caused as a result of the Oculentis lenses.
“We sometimes take our eyesight for granted, but problems with vision can have a significant impact on a person’s quality of life.”